| MORE REPORTS | |
 |
The 4th Canadian Colloquium on Dementia was held October 18-20, 2007 in Vancouver, BC. The 4th CCD was a meeting of professionals devoted to presenting cutting-edge research on dementia, and educating participants on trends in the diagnosis and treatment of Alzheimer’s disease and other dementias. Please note that the online, video portions of this report require the most recent version of Adobe Flash Player, which can be obtained as a free download by clicking here. |
|
The Latest Research in Dementia Care: Views from the 4th Annual Canadian Colloquium on Dementia Speaker: Dr. Ron Keren, MD, FRCPC, 4th CCD Chair; Clinical Director, University Health Network and Whitby Mental Health Centre Memory Clinics; Assistant Professor, University of Toronto,Toronto, ON. Working Effectively with Community Partners in Dementia Care Speaker: Dr. Carole A. Cohen, MD,FRCPC, Associate Professor, Department of Psychiatry, University of Toronto; Clinical Director, Community Psychiatric Services for the Elderly, Sunnybrook and Women’s College Health Sciences Centre; Toronto, ON. Alzheimer’s Disease: Treatments on the Horizon Speaker: Dr. Serge Gauthier, MD, FRCPC, Director, Alzheimer Disease and Related Disorders Research Unit, McGill Centre for Studies in Aging, Montreal,QC.  The Alzheimer’s Disease Symposium: Immunotherapies, the Question of Cures, and the Amyloid Hypothesis Natural Human Antibodies for Alzheimer Disease Speaker: Dr. Norman Relkin, MD, PhD, Director, Cornell Memory Disorders Program, New York Presbyterian Hospital; Weill Cornell Medical College, New York. Curing Alzheimer’s Disease: The Case of tau and GSK-3 Speaker: Dr. Simon Lovestone, PhD, MRCPsych, Professor, Old Age Psychiatry, MRC Centre for Neurodegeneration Research; Departments of Old Age Psychiatry and Neuroscience, King's College London, Institute of Psychiatry, London, England, UK. The Pros and Cons of the Amyloid Hypothesis of Alzheimer’s Disease Speaker: Andrea LeBlanc, PhD, Professor and McGill Dawson Scholar, Department of Neurology and Neurosurgery, McGill University; Project Director, Bloomfield Centre for Research in Aging, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, Montreal,QC. Antiamyloid Immunotherapy: What do the vessels think? Speaker: Steven M. Greenberg, MD, PhD, Director, Hemorrhagic Stroke Research Program, Massachusetts General Hospital; Associate Professor of Neurology, Harvard Medical School, Boston, MA, USA.  Idiopathic Normal Pressure Hydrocephalus Speaker: Dr. Norman Relkin, MD, PhD, Director, Cornell Memory Disorders Program; Associate Professor of Clinical Neurology and Neuroscience,Weill Cornell Medical College; Associate Attending Neurologist, NewYork-Presbyterian Hospital, New York, NY, USA. Dementia and Depression: The Importance of Recognizing their Relationship Speaker: Dr. Kristine Yaffe, MD, Associate Professor, Department of Psychiatry, Neurology and Epidemiology; Co-director of the Clinical and Translational Sciences Training Program, University of California, San Francisco; San Francisco, CA, USA. |
|
The 4th Canadian Colloquium on Dementia
Disclaimer: While every attempt is made to ensure that drug dosages provided within the text of this journal and the website are accurate, readers are urged to check drug package inserts before prescribing. Views and opinions in this publication and the website are not necessarily endorsed by or reflective of those of the publisher.
